Activity of the growth hormone/insulin-like growth factor-I axis in critically ill children

被引:3
|
作者
Gardelis, JG
Hatzis, TD
Stamogiannou, LN
Dona, AA
Fotinou, AD
Brestas, PS
Constantopoulos, AG
机构
[1] P&A Kryiakou Childrens Hosp, Dept Pediat 1, Athens, Greece
[2] Aghia Sophia Childrens Hosp, Pediat Intens Care Unit, Athens, Greece
[3] Univ Athens, Dept Forens Med & Toxicol, Athens, Greece
[4] PA Kyriakou Childrens Hosp, Hormonol Lab, Athens, Greece
[5] Univ Athens, Sch Nursing, Dept Publ Hlth, GR-10679 Athens, Greece
[6] Univ Athens, Dept Pediat 2, GR-10679 Athens, Greece
来源
关键词
critical illness; trauma; sepsis; growth hormone; insulin-like growth factor (IGF)-I; IGF-II; IGF binding protein-1; IGF binding protein-3;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Critical illness has an important impact on the human endocrine system. Very few studies have been performed to elucidate the alterations of the GH/IGF-I axis in acutely ill children. The aim of this study was to investigate several parameters of this axis in children with trauma (TRA) and sepsis (SEP) requiring admission to the pediatric intensive care unit (PICU). A total of 16 children, ten with TRA and six with SEP (age 1-10 years) as well as 18 healthy children (CS) of similar age and gender were included in the study. Two children, one with TRA and one with SEP, died. Serum IGF-I and -II, IGFBP-I and -3, and GH levels were measured on days 1, 3 and 7 after admission. GH levels were higher in the patients than in CS (p = 0.04), with no difference between TRA and SEP, and were elevated during PICU stay (p = 0.05). Serum TGF-I, -II and IGFBP-3 were lower in the patients than in CS (p = 0.03, 0.02 and 0.001, respectively) with a tendency to increase up to day 7. Finally, IGFBP-1 levels were similar in the patients and CS. These findings indicate that critically ill children are characterized by low levels of IGF-I and -II as well as IGFBP-3 accompanied by elevated levels of GH, probably reflecting the development of peripheral GH resistance. No significant differences were found between the different catabolic conditions, sepsis and trauma.
引用
收藏
页码:363 / 372
页数:10
相关论文
共 50 条
  • [1] The growth hormone insulin-like growth factor-I axis
    Krishna, AY
    Phillips, LS
    GROWTH FACTORS AND WOUND HEALING: BASIC SCIENCE AND POTENTIAL CLINICAL APPLICATIONS, 1997, : 56 - 76
  • [2] Protein metabolism and the use of growth hormone and insulin-like growth factor-I in the critically ill patient
    Carroll, PV
    GROWTH HORMONE & IGF RESEARCH, 1999, 9 (06) : 400 - 413
  • [3] The growth hormone/insulin-like growth factor-i axis in exercise and sport
    Gibney, James
    Healy, Marie-Louise
    Soenksen, Peter H.
    ENDOCRINE REVIEWS, 2007, 28 (06) : 603 - 624
  • [4] Genetic disorders in the growth hormone - Insulin-like growth factor-I axis
    Walenkamp, M. J. E.
    Wit, J. M.
    HORMONE RESEARCH, 2006, 66 (05) : 221 - 230
  • [5] Mouse models for understanding the growth hormone insulin-like growth factor-I axis
    Rosen, Clifford J.
    HORMONE RESEARCH, 2007, 68 : 2 - 4
  • [6] Regulation of the growth hormone/insulin-like growth factor-I axis in HIV disease
    Meininger, G
    Grinspoon, S
    ENDOCRINOLOGIST, 2001, 11 (03): : 188 - 195
  • [7] Sex steroids and the growth hormone/insulin-like growth factor-I axis in adults
    Jorgensen, JOL
    Christensen, JJ
    Vestergaard, E
    Fisker, S
    Ovesen, P
    Christiansen, JS
    HORMONE RESEARCH, 2005, 64 : 37 - 40
  • [8] Growth hormone and insulin-like growth factor-I axis in type 1 diabetes
    Nambam, Bimota
    Schatz, Desmond
    GROWTH HORMONE & IGF RESEARCH, 2018, 38 : 49 - 52
  • [9] Association between the insulin resistance of puberty and the insulin-like growth factor-I/growth hormone axis
    Moran, A
    Jacobs, DR
    Steinberger, J
    Cohen, P
    Hong, CP
    Prineas, R
    Sinaiko, AR
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (10): : 4817 - 4820
  • [10] The growth hormone-insulin-like growth factor-I axis
    RodriguezArnao, J
    Diez, JJ
    GomezPan, A
    CLINICAL SCIENCE, 1996, 90 (03) : 169 - 171